Dental Alloys Market by Alloy Type (Base Metal Alloys, Noble Alloys, Precious Alloys), Manufacturing Process (3D Printing, Cad/Cam Milling, Casting), Material, Product Form, Application, End Use, Distribution Channel - Global Forecast 2025-2032
Description
The Dental Alloys Market was valued at USD 2.55 billion in 2024 and is projected to grow to USD 2.89 billion in 2025, with a CAGR of 13.11%, reaching USD 6.84 billion by 2032.
Authoritative orientation to the technical, clinical, and operational importance of dental alloys that frames strategic decision-making for stakeholders
Dental alloys occupy a pivotal role within restorative and prosthetic dentistry, underpinning prostheses from crowns and bridges to removable and orthodontic appliances. Materials science, coupled with evolving clinical requirements, drives continuous refinement of alloy compositions and fabrication techniques. Clinicians prioritize biocompatibility, mechanical performance, and long-term corrosion resistance, while laboratory technicians emphasize consistency, machinability, and compatibility with digital workflows. Consequently, the alloy landscape functions at the intersection of clinical outcomes, laboratory productivity, and supply chain resilience.
As the industry transitions from traditional casting toward digitally enabled manufacturing, the alloy portfolio must satisfy both legacy processes and additive or subtractive digital workflows. Meanwhile, material availability, regulatory scrutiny, and commercial distribution patterns influence adoption cycles. Stakeholders need a clear, practical overview that synthesizes technical characteristics with business implications so they can prioritize investments in materials, equipment, and partnerships that deliver reproducible clinical quality and operational efficiency.
How converging advances in additive manufacturing, material refinement, regulatory rigor, and clinical expectations are redefining the dental alloys ecosystem
Recent years have witnessed transformative shifts across materials science, manufacturing, and clinical expectations that together reshape the dental alloys landscape. Advances in additive manufacturing, improved powder metallurgy, and precision CAD/CAM milling have expanded the design envelope and accelerated turnaround times. Simultaneously, clinicians increasingly demand metals and metal alloys that pair favorable biomechanical properties with improved aesthetics and biological compatibility, prompting suppliers to refine compositions and surface treatments.
The supply chain has also evolved: tighter raw material controls, heightened regulatory oversight, and diversification of distribution channels are prompting laboratories and clinics to rethink procurement strategies. Digital workflows are bridging the gap between laboratory capabilities and clinical requirements, enabling decentralized production and customized prostheses. In addition, environmental and occupational safety considerations are driving interest in alloys with reduced toxicological risk and in-process technologies that minimize waste. Taken together, these shifts create both challenges and opportunities for manufacturers, distributors, and clinical partners seeking to adapt and differentiate.
Comprehensive assessment of the multifaceted effects arising from 2025 tariff adjustments on procurement, supply continuity, and strategic sourcing of dental alloys
Tariff adjustments introduced in 2025 have exerted layered effects across procurement, pricing structures, and supply chain decisions for dental alloys. Increased import duties on select raw metals and finished components have encouraged some laboratories and manufacturers to source domestically where feasible or to consolidate purchases with preferred suppliers to mitigate per-unit cost volatility. At the same time, tariffs have highlighted the importance of transparent origin tracking and contractual protections, as well as the value of diversified supplier networks to maintain continuity of supplies for critical alloys such as cobalt chromium, nickel chromium, and precious metal blends.
Consequently, purchasing teams and distributors are reassessing inventory policies and lead-time buffers to accommodate potential customs-related disruptions. Clinicians and laboratory managers are prioritizing procurement strategies that reduce exposure to single-source imports, including longer-term agreements with reliable domestic mills or regional partners. For OEMs and service providers, the tariffs have accelerated internal programs focused on process optimization, yield improvement, and alternative material qualification, all intended to preserve clinical performance while absorbing or offsetting increased input costs.
Integrated segmentation analysis that reveals where alloy chemistry, clinical application, manufacturing process, distribution channel, and product form intersect to drive purchasing decisions
A segmentation-driven understanding clarifies where performance requirements and commercial dynamics diverge across the dental alloys spectrum. Based on alloy type, product offerings span Base Metal Alloys, which include cobalt chromium, nickel chromium, and titanium variants; Noble Alloys, which encompass gold-based noble blends and palladium-rich noble formulations; and Precious Alloys, represented by gold, palladium, and platinum compositions. Each alloy family presents distinct machinability profiles, corrosion behaviors, and clinical trade-offs that inform material selection.
When viewed through the lens of application, alloys are deployed across crowns and bridges, dentures, inlays and onlays, and orthodontic appliances, with functional demands varying by prosthesis type. Manufacturing process segmentation distinguishes 3D printing, CAD/CAM milling, and casting workflows, each imposing different material feedstock and design constraints. Material-level segmentation highlights the specific properties of chromium cobalt, gold, nickel chromium, palladium, platinum, and titanium, while end use differentiates requirements for dental clinics, dental laboratories, and hospitals. Distribution channel distinctions between direct sales, distributors, and online platforms influence service levels and lead times, and product form segmentation across blocks, disks, ingots, and powders affects compatibility with additive or subtractive equipment. Synthesizing these dimensions reveals where technical performance, clinical acceptance, and commercial access converge, enabling targeted product development, validation pathways, and go-to-market approaches that align with how practitioners and labs actually work.
Regional strategic intelligence highlighting clinical practice patterns, regulatory nuances, and distribution dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics shape material preferences, regulatory expectations, and commercial models in ways that have practical implications for suppliers and clinical users. In the Americas, demand patterns reflect a blend of advanced restorative techniques and an established laboratory base that values rapid digital workflows and readily available technical support. Payment systems and clinical reimbursement frameworks influence procurement timetables and the adoption cadence for new materials and processes.
Europe, Middle East & Africa encompasses a wide regulatory and clinical practice spectrum, from stringent material safety standards in parts of Western Europe to cost-sensitive and access-driven markets in other areas. Manufacturers operating in this region often adapt product portfolios to meet regional certification pathways and a heterogeneous distribution landscape. In the Asia-Pacific region, rapid capacity expansion, a growing dental services market, and increasing adoption of digital manufacturing contribute to a competitive supplier environment where local production and cost-efficiency are key differentiators. Understanding these regional nuances supports more effective distribution strategies, regulatory planning, and partnerships that respect local clinical protocols and procurement behaviors.
Company strategic archetypes that combine material innovation, digital workflow integration, supply chain transparency, and service models to capture clinical and laboratory preference
Company-level strategies in the dental alloys domain increasingly emphasize integrated solutions that combine material performance with digital fabrication support, regulatory assurance, and localized service. Leading firms invest in application-driven alloy development, collaborating closely with dental laboratories and academic centers to validate clinical workflows and to accelerate adoption. At the same time, firms that prioritize supply chain resilience and transparent sourcing gain a commercial edge, particularly in environments where raw material traceability and compliance have become more visible priorities.
Partnership models that bundle alloy supply with software, milling or additive hardware compatibility, and technical training reduce friction for laboratory uptake while improving downstream clinical predictability. Furthermore, companies that demonstrate rigorous quality controls across product forms-blocks, disks, ingots, and powders-and that provide robust documentation for biocompatibility and corrosion resistance position themselves favorably with procurement teams and regulatory reviewers. Strategic distribution networks that balance direct sales, distributor partnerships, and selective online platforms enable companies to match service intensity with customer expectations across different geographies and end-use settings.
Practical and actionable steps for manufacturers, laboratories, and clinical leaders to enhance reliability, regulatory readiness, and supply continuity amid evolving conditions
Industry leaders and laboratory managers can adopt practical measures to strengthen competitiveness and clinical reliability in light of the current dynamics. First, prioritize qualification protocols that validate alloy behavior across both additive and subtractive manufacturing methods, ensuring that new material introductions demonstrate consistent mechanical properties, fit accuracy, and long-term corrosion resistance. Second, diversify sourcing strategies by establishing vetted regional suppliers and by negotiating contractual terms that include contingency provisions for tariff-related or logistics disruptions.
Third, invest in training programs that align laboratory technicians and clinicians to shared digital workflows, maximizing the benefits of CAD/CAM and 3D printing while minimizing rework and remakes. Fourth, implement quality documentation and traceability systems that record material provenance, lot performance, and clinical feedback, thereby improving regulatory readiness and customer confidence. Finally, consider strategic partnerships that bundle material supply with equipment compatibility assurances, technical support, and clinical validation studies to smooth adoption curves and to demonstrate comparative clinical value.
Transparent and reproducible research methodology combining primary stakeholder engagement, technical literature review, and cross-segmentation validation to ensure actionable insights
The research underpinning these insights synthesized primary stakeholder interviews, technical literature, and process-level validation exercises to produce a holistic perspective on dental alloys. Primary engagements included structured interviews with practicing clinicians, dental laboratory managers, materials scientists, and procurement leaders to capture firsthand priorities and pain points. Secondary research comprised peer-reviewed materials science publications, regulatory documentation, and technology white papers that illuminate performance characteristics and emerging fabrication methods.
Analytical steps combined qualitative thematic coding with cross-segmentation mapping to identify where alloy properties, manufacturing processes, and end-use requirements intersect. Validation procedures included targeted supplier due diligence and iterative reviews with clinical experts to ensure that technical inferences aligned with real-world practice. Throughout the methodology, emphasis remained on transparency of data sources, reproducibility of validation protocols, and contextual interpretation rather than extrapolative forecasting, enabling readers to apply the findings directly to operational and strategic decisions.
Conclusive synthesis that ties material, manufacturing, regulatory, and commercial threads into pragmatic guidance for stakeholders navigating the dental alloys landscape
This executive summary synthesizes how material science advances, manufacturing evolution, regulatory developments, and commercial pressures collectively shape practice and procurement decisions for dental alloys. Clinicians and laboratory managers face a complex set of trade-offs between mechanical performance, biological compatibility, manufacturability, and cost exposure that demand integrated evaluation criteria. Equally, suppliers and distributors must navigate regional regulatory variations, evolving digital workflows, and supply chain sensitivities to deliver reliable solutions that match clinical expectations.
Moving forward, success will hinge on those organizations that couple rigorous material validation with service-oriented distribution and that invest in traceability, training, and process optimization. By aligning product portfolios with the diverse needs of dental clinics, dental laboratories, and hospitals, and by ensuring compatibility across 3D printing, CAD/CAM milling, and casting processes, stakeholders can minimize clinical risk and enhance operational efficiency. Ultimately, pragmatic collaboration among material scientists, clinicians, and supply chain partners will be critical to unlocking the next wave of improvement in restorative outcomes and laboratory productivity.
Note: PDF & Excel + Online Access - 1 Year
Authoritative orientation to the technical, clinical, and operational importance of dental alloys that frames strategic decision-making for stakeholders
Dental alloys occupy a pivotal role within restorative and prosthetic dentistry, underpinning prostheses from crowns and bridges to removable and orthodontic appliances. Materials science, coupled with evolving clinical requirements, drives continuous refinement of alloy compositions and fabrication techniques. Clinicians prioritize biocompatibility, mechanical performance, and long-term corrosion resistance, while laboratory technicians emphasize consistency, machinability, and compatibility with digital workflows. Consequently, the alloy landscape functions at the intersection of clinical outcomes, laboratory productivity, and supply chain resilience.
As the industry transitions from traditional casting toward digitally enabled manufacturing, the alloy portfolio must satisfy both legacy processes and additive or subtractive digital workflows. Meanwhile, material availability, regulatory scrutiny, and commercial distribution patterns influence adoption cycles. Stakeholders need a clear, practical overview that synthesizes technical characteristics with business implications so they can prioritize investments in materials, equipment, and partnerships that deliver reproducible clinical quality and operational efficiency.
How converging advances in additive manufacturing, material refinement, regulatory rigor, and clinical expectations are redefining the dental alloys ecosystem
Recent years have witnessed transformative shifts across materials science, manufacturing, and clinical expectations that together reshape the dental alloys landscape. Advances in additive manufacturing, improved powder metallurgy, and precision CAD/CAM milling have expanded the design envelope and accelerated turnaround times. Simultaneously, clinicians increasingly demand metals and metal alloys that pair favorable biomechanical properties with improved aesthetics and biological compatibility, prompting suppliers to refine compositions and surface treatments.
The supply chain has also evolved: tighter raw material controls, heightened regulatory oversight, and diversification of distribution channels are prompting laboratories and clinics to rethink procurement strategies. Digital workflows are bridging the gap between laboratory capabilities and clinical requirements, enabling decentralized production and customized prostheses. In addition, environmental and occupational safety considerations are driving interest in alloys with reduced toxicological risk and in-process technologies that minimize waste. Taken together, these shifts create both challenges and opportunities for manufacturers, distributors, and clinical partners seeking to adapt and differentiate.
Comprehensive assessment of the multifaceted effects arising from 2025 tariff adjustments on procurement, supply continuity, and strategic sourcing of dental alloys
Tariff adjustments introduced in 2025 have exerted layered effects across procurement, pricing structures, and supply chain decisions for dental alloys. Increased import duties on select raw metals and finished components have encouraged some laboratories and manufacturers to source domestically where feasible or to consolidate purchases with preferred suppliers to mitigate per-unit cost volatility. At the same time, tariffs have highlighted the importance of transparent origin tracking and contractual protections, as well as the value of diversified supplier networks to maintain continuity of supplies for critical alloys such as cobalt chromium, nickel chromium, and precious metal blends.
Consequently, purchasing teams and distributors are reassessing inventory policies and lead-time buffers to accommodate potential customs-related disruptions. Clinicians and laboratory managers are prioritizing procurement strategies that reduce exposure to single-source imports, including longer-term agreements with reliable domestic mills or regional partners. For OEMs and service providers, the tariffs have accelerated internal programs focused on process optimization, yield improvement, and alternative material qualification, all intended to preserve clinical performance while absorbing or offsetting increased input costs.
Integrated segmentation analysis that reveals where alloy chemistry, clinical application, manufacturing process, distribution channel, and product form intersect to drive purchasing decisions
A segmentation-driven understanding clarifies where performance requirements and commercial dynamics diverge across the dental alloys spectrum. Based on alloy type, product offerings span Base Metal Alloys, which include cobalt chromium, nickel chromium, and titanium variants; Noble Alloys, which encompass gold-based noble blends and palladium-rich noble formulations; and Precious Alloys, represented by gold, palladium, and platinum compositions. Each alloy family presents distinct machinability profiles, corrosion behaviors, and clinical trade-offs that inform material selection.
When viewed through the lens of application, alloys are deployed across crowns and bridges, dentures, inlays and onlays, and orthodontic appliances, with functional demands varying by prosthesis type. Manufacturing process segmentation distinguishes 3D printing, CAD/CAM milling, and casting workflows, each imposing different material feedstock and design constraints. Material-level segmentation highlights the specific properties of chromium cobalt, gold, nickel chromium, palladium, platinum, and titanium, while end use differentiates requirements for dental clinics, dental laboratories, and hospitals. Distribution channel distinctions between direct sales, distributors, and online platforms influence service levels and lead times, and product form segmentation across blocks, disks, ingots, and powders affects compatibility with additive or subtractive equipment. Synthesizing these dimensions reveals where technical performance, clinical acceptance, and commercial access converge, enabling targeted product development, validation pathways, and go-to-market approaches that align with how practitioners and labs actually work.
Regional strategic intelligence highlighting clinical practice patterns, regulatory nuances, and distribution dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific
Regional dynamics shape material preferences, regulatory expectations, and commercial models in ways that have practical implications for suppliers and clinical users. In the Americas, demand patterns reflect a blend of advanced restorative techniques and an established laboratory base that values rapid digital workflows and readily available technical support. Payment systems and clinical reimbursement frameworks influence procurement timetables and the adoption cadence for new materials and processes.
Europe, Middle East & Africa encompasses a wide regulatory and clinical practice spectrum, from stringent material safety standards in parts of Western Europe to cost-sensitive and access-driven markets in other areas. Manufacturers operating in this region often adapt product portfolios to meet regional certification pathways and a heterogeneous distribution landscape. In the Asia-Pacific region, rapid capacity expansion, a growing dental services market, and increasing adoption of digital manufacturing contribute to a competitive supplier environment where local production and cost-efficiency are key differentiators. Understanding these regional nuances supports more effective distribution strategies, regulatory planning, and partnerships that respect local clinical protocols and procurement behaviors.
Company strategic archetypes that combine material innovation, digital workflow integration, supply chain transparency, and service models to capture clinical and laboratory preference
Company-level strategies in the dental alloys domain increasingly emphasize integrated solutions that combine material performance with digital fabrication support, regulatory assurance, and localized service. Leading firms invest in application-driven alloy development, collaborating closely with dental laboratories and academic centers to validate clinical workflows and to accelerate adoption. At the same time, firms that prioritize supply chain resilience and transparent sourcing gain a commercial edge, particularly in environments where raw material traceability and compliance have become more visible priorities.
Partnership models that bundle alloy supply with software, milling or additive hardware compatibility, and technical training reduce friction for laboratory uptake while improving downstream clinical predictability. Furthermore, companies that demonstrate rigorous quality controls across product forms-blocks, disks, ingots, and powders-and that provide robust documentation for biocompatibility and corrosion resistance position themselves favorably with procurement teams and regulatory reviewers. Strategic distribution networks that balance direct sales, distributor partnerships, and selective online platforms enable companies to match service intensity with customer expectations across different geographies and end-use settings.
Practical and actionable steps for manufacturers, laboratories, and clinical leaders to enhance reliability, regulatory readiness, and supply continuity amid evolving conditions
Industry leaders and laboratory managers can adopt practical measures to strengthen competitiveness and clinical reliability in light of the current dynamics. First, prioritize qualification protocols that validate alloy behavior across both additive and subtractive manufacturing methods, ensuring that new material introductions demonstrate consistent mechanical properties, fit accuracy, and long-term corrosion resistance. Second, diversify sourcing strategies by establishing vetted regional suppliers and by negotiating contractual terms that include contingency provisions for tariff-related or logistics disruptions.
Third, invest in training programs that align laboratory technicians and clinicians to shared digital workflows, maximizing the benefits of CAD/CAM and 3D printing while minimizing rework and remakes. Fourth, implement quality documentation and traceability systems that record material provenance, lot performance, and clinical feedback, thereby improving regulatory readiness and customer confidence. Finally, consider strategic partnerships that bundle material supply with equipment compatibility assurances, technical support, and clinical validation studies to smooth adoption curves and to demonstrate comparative clinical value.
Transparent and reproducible research methodology combining primary stakeholder engagement, technical literature review, and cross-segmentation validation to ensure actionable insights
The research underpinning these insights synthesized primary stakeholder interviews, technical literature, and process-level validation exercises to produce a holistic perspective on dental alloys. Primary engagements included structured interviews with practicing clinicians, dental laboratory managers, materials scientists, and procurement leaders to capture firsthand priorities and pain points. Secondary research comprised peer-reviewed materials science publications, regulatory documentation, and technology white papers that illuminate performance characteristics and emerging fabrication methods.
Analytical steps combined qualitative thematic coding with cross-segmentation mapping to identify where alloy properties, manufacturing processes, and end-use requirements intersect. Validation procedures included targeted supplier due diligence and iterative reviews with clinical experts to ensure that technical inferences aligned with real-world practice. Throughout the methodology, emphasis remained on transparency of data sources, reproducibility of validation protocols, and contextual interpretation rather than extrapolative forecasting, enabling readers to apply the findings directly to operational and strategic decisions.
Conclusive synthesis that ties material, manufacturing, regulatory, and commercial threads into pragmatic guidance for stakeholders navigating the dental alloys landscape
This executive summary synthesizes how material science advances, manufacturing evolution, regulatory developments, and commercial pressures collectively shape practice and procurement decisions for dental alloys. Clinicians and laboratory managers face a complex set of trade-offs between mechanical performance, biological compatibility, manufacturability, and cost exposure that demand integrated evaluation criteria. Equally, suppliers and distributors must navigate regional regulatory variations, evolving digital workflows, and supply chain sensitivities to deliver reliable solutions that match clinical expectations.
Moving forward, success will hinge on those organizations that couple rigorous material validation with service-oriented distribution and that invest in traceability, training, and process optimization. By aligning product portfolios with the diverse needs of dental clinics, dental laboratories, and hospitals, and by ensuring compatibility across 3D printing, CAD/CAM milling, and casting processes, stakeholders can minimize clinical risk and enhance operational efficiency. Ultimately, pragmatic collaboration among material scientists, clinicians, and supply chain partners will be critical to unlocking the next wave of improvement in restorative outcomes and laboratory productivity.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rising adoption of biocompatible titanium and zirconium dental alloys for implant restorations
- 5.2. Increasing demand for low-nickel dental alloys to reduce hypersensitivity reactions in patients
- 5.3. Integration of 3D printing technologies with advanced dental alloy formulations for custom prosthetics
- 5.4. Growth of CAD/CAM-milled cobalt-chromium dental frameworks for improved precision and strength
- 5.5. Emergence of high-performance gold palladium alloys in aesthetic anterior dental restorations
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Dental Alloys Market, by Alloy Type
- 8.1. Base Metal Alloys
- 8.1.1. Cobalt Chromium
- 8.1.2. Nickel Chromium
- 8.1.3. Titanium
- 8.2. Noble Alloys
- 8.2.1. Gold Noble Alloys
- 8.2.2. Palladium Noble Alloys
- 8.3. Precious Alloys
- 8.3.1. Gold Alloys
- 8.3.2. Palladium Alloys
- 8.3.3. Platinum Alloys
- 9. Dental Alloys Market, by Manufacturing Process
- 9.1. 3D Printing
- 9.2. Cad/Cam Milling
- 9.3. Casting
- 10. Dental Alloys Market, by Material
- 10.1. Chromium Cobalt
- 10.2. Gold
- 10.3. Nickel Chromium
- 10.4. Palladium
- 10.5. Platinum
- 10.6. Titanium
- 11. Dental Alloys Market, by Product Form
- 11.1. Blocks
- 11.2. Disks
- 11.3. Ingots
- 11.4. Powders
- 12. Dental Alloys Market, by Application
- 12.1. Crowns And Bridges
- 12.2. Dentures
- 12.3. Inlays And Onlays
- 12.4. Orthodontic Appliances
- 13. Dental Alloys Market, by End Use
- 13.1. Dental Clinics
- 13.2. Dental Laboratories
- 13.3. Hospitals
- 14. Dental Alloys Market, by Distribution Channel
- 14.1. Direct Sales
- 14.2. Distributors
- 14.3. Online Platforms
- 15. Dental Alloys Market, by Region
- 15.1. Americas
- 15.1.1. North America
- 15.1.2. Latin America
- 15.2. Europe, Middle East & Africa
- 15.2.1. Europe
- 15.2.2. Middle East
- 15.2.3. Africa
- 15.3. Asia-Pacific
- 16. Dental Alloys Market, by Group
- 16.1. ASEAN
- 16.2. GCC
- 16.3. European Union
- 16.4. BRICS
- 16.5. G7
- 16.6. NATO
- 17. Dental Alloys Market, by Country
- 17.1. United States
- 17.2. Canada
- 17.3. Mexico
- 17.4. Brazil
- 17.5. United Kingdom
- 17.6. Germany
- 17.7. France
- 17.8. Russia
- 17.9. Italy
- 17.10. Spain
- 17.11. China
- 17.12. India
- 17.13. Japan
- 17.14. Australia
- 17.15. South Korea
- 18. Competitive Landscape
- 18.1. Market Share Analysis, 2024
- 18.2. FPNV Positioning Matrix, 2024
- 18.3. Competitive Analysis
- 18.3.1. DENTSPLY SIRONA Inc.
- 18.3.2. Ivoclar Vivadent AG
- 18.3.3. 3M Company
- 18.3.4. Heraeus Kulzer GmbH
- 18.3.5. Zimmer Biomet Holdings, Inc.
- 18.3.6. Straumann Holding AG
- 18.3.7. Nobel Biocare Services AG
- 18.3.8. Argen Corporation
- 18.3.9. BEGO Bremer Goldschlägerei Wilh. Herbst GmbH & Co. KG
- 18.3.10. DEGUDENT GmbH
- 18.3.11. Kulzer GmbH
- 18.3.12. GC Corporation
- 18.3.13. Kuraray Noritake Dental Inc.
- 18.3.14. Dentaurum GmbH & Co. KG
- 18.3.15. Aalba Dent Inc.
- 18.3.16. Jensen Dental
- 18.3.17. Sterngold Dental LLC
- 18.3.18. Yamamoto Precious Metal Co., Ltd.
- 18.3.19. Cendres+MĂ©taux SA
- 18.3.20. Shofu Dental Corporation
- 18.3.21. Wieland Dental + Technik GmbH & Co. KG
- 18.3.22. Zirkonzahn GmbH
- 18.3.23. Henry Schein, Inc.
- 18.3.24. Indium Corporation
- 18.3.25. Metalor Technologies SA
- 18.3.26. Osstem Implant Co., Ltd.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
